Differential effects of the novel non-peptidic opioid 4-tyrosylamido-6-benzyl-1,2,3,4 tetrahydroquinoline (CGPM-9) on in vitro rat t lymphocyte and macrophage functions
Me. Hicks et al., Differential effects of the novel non-peptidic opioid 4-tyrosylamido-6-benzyl-1,2,3,4 tetrahydroquinoline (CGPM-9) on in vitro rat t lymphocyte and macrophage functions, LIFE SCI, 68(24), 2001, pp. 2685-2694
Opioid receptors have been reported on immune cells of several species and
shown to subserve effector functions of these cell types. Mu-selective opio
id agonists such as morphine are immunosuppressive, whereas certain 6-opioi
d receptor-selective agonists have been associated with immunopotentiation.
We have previously shown that intracerebroventricular administration of th
e non-peptidic 6-opioid receptor agonists did not alter certain parameters
of immunocompetence. In this study, we evaluated the in vitro effects of th
e novel non-peptidic opioid 4-tyrosylamido-6-benzyl-1,2,3,4 tetrahy-droquin
oline (CGPM-9) on lymphocyte and macrophage functions. We demonstrated that
CGPM-9 enhanced rat thymic lymphocyte proliferative response to concanaval
in A (2.85- to 5.5-fold increases), and suppressed LPS-induced nitric oxide
(67 to 72 percent reduction) and TNF-alpha production (46 percent reductio
n) by peritoneal macrophages, compared with untreated control. The mu -opio
id receptor selective antagonist CTOP used at equimolar doses, significantl
y suppressed the effect of CGPM-9 on lymphocyte and macrophage functions (C
TOP alone did not show any effect on lymphocyte or macrophage functions). I
n summary, CGPM-9 activated thymic lymphocyte proliferation and suppressed
macrophage functions by acting at mu -opioid receptors. This suggests that
opioid receptors on immunocytes may be coupled to different signaling pathw
ays depending on the cell type and effector function being analyzed. The me
chanism(s) associated with the differential effect of CGPM-9 on these immun
e cells remains to be elucidated. The pharmacotherapeutic potential for com
pounds such as CGPM-9 which potentiate T lymphocyte proliferation and suppr
ess production of macrophage-derived inflammatory cytokines is substantial
in research and clinical medicine. (C) 2001 Elsevier Science Inc. All right
s reserved.